Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?

Which should be the correct treatment for monoclonal gammopathy of renal significance with... International Urology and Nephrology (2018) 50:1365–1366 https://doi.org/10.1007/s11255-018-1896-8 NEPHROLOGY - LE T TER TO THE EDITOR Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy? 1 2 Mariana Ciocchini  · Carlos G. Musso Received: 2 May 2018 / Accepted: 15 May 2018 / Published online: 28 May 2018 © Springer Science+Business Media B.V., part of Springer Nature 2018 Editor, by: mesangiolysis, microaneurysms, endothelial swelling, cellular proliferation with endothelial or membranopro- Monoclonal gammopathy of renal significance (MGRS) liferative pattern (depending on its degree of evolution) is a recently described hemato-nephrological meta-entity and patchy subcortical renal atrophy according to small induced by monoclonal immunoglobulins (Ig) or humoral artery endarteritis. The presence of thrombi in capillaries is factors secreted by small B-cell clones. MGRS can show a pathognomonic of TMA but their absence does not rule out broad spectrum of renal histopathological patterns which its diagnosis. Moreover, haematological alterations are not can even coexist in the same patient [1, 2]. mandatory for TMA diagnosis [4–6]. C3 glomerulopathy (C3G) and atypical hemolytic uremic C3G and aHUS can overlap, being reported that 6% of syndrome (aHUS), which are the prototype of complement- C3G with monoclonal Ig has http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Urology and Nephrology Springer Journals

Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?

Download PDF
2 pages

Loading next page...
 
/lp/springer_journal/which-should-be-the-correct-treatment-for-monoclonal-gammopathy-of-EktzAE7aNK
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media B.V., part of Springer Nature
Subject
Medicine & Public Health; Nephrology; Urology
ISSN
0301-1623
eISSN
1573-2584
DOI
10.1007/s11255-018-1896-8
Publisher site
See Article on Publisher Site

Abstract

International Urology and Nephrology (2018) 50:1365–1366 https://doi.org/10.1007/s11255-018-1896-8 NEPHROLOGY - LE T TER TO THE EDITOR Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy? 1 2 Mariana Ciocchini  · Carlos G. Musso Received: 2 May 2018 / Accepted: 15 May 2018 / Published online: 28 May 2018 © Springer Science+Business Media B.V., part of Springer Nature 2018 Editor, by: mesangiolysis, microaneurysms, endothelial swelling, cellular proliferation with endothelial or membranopro- Monoclonal gammopathy of renal significance (MGRS) liferative pattern (depending on its degree of evolution) is a recently described hemato-nephrological meta-entity and patchy subcortical renal atrophy according to small induced by monoclonal immunoglobulins (Ig) or humoral artery endarteritis. The presence of thrombi in capillaries is factors secreted by small B-cell clones. MGRS can show a pathognomonic of TMA but their absence does not rule out broad spectrum of renal histopathological patterns which its diagnosis. Moreover, haematological alterations are not can even coexist in the same patient [1, 2]. mandatory for TMA diagnosis [4–6]. C3 glomerulopathy (C3G) and atypical hemolytic uremic C3G and aHUS can overlap, being reported that 6% of syndrome (aHUS), which are the prototype of complement- C3G with monoclonal Ig has

Journal

International Urology and Nephrology – Springer Journals

Published: May 28, 2018

References

  • Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity
    Ciocchini, M; Arbelbide, J; Musso, CG
  • What is the place of POEMS syndrome in the current classification of monoclonal gammopathies of renal significance?
    Ciocchini, M; Musso, CG
  • Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy
    Chauvet, S; Frémeaux-Bacchi, V; Petitprez, F; Karras, A; Daniel, L; Burtey, S; Choukroun, G; Delmas, Y; Guerrot, D; François, A; Quintrec, M; Javaugue, V; Ribes, D; Vrigneaud, L; Arnulf, B; Goujon, JM; Ronco, P; Touchard, G; Bridoux, F
  • Thrombotic microangiopathy associated with monoclonal gammopathy
    Ravindran, A; Go, RS; Fervenza, FC; Sethi, S
  • Conference participants. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference
    Goodship, TH; Cook, HT; Fakhouri, F; Fervenza, FC; Frémeaux-Bacchi, V; Kavanagh, D; Nester, CM; Noris, M; Pickering, MC; Rodríguez de Córdoba, S; Roumenina, LT; Sethi, S; Smith, RJ
  • Manifestationes rénales du symdrome POEMS
    Soubrier, M; Deteix, P; Derray, G; Dubost, JJ; Sauvezie, B; Chapman, A; Bussière, JL
  • C3 glomerulonephritis associated with monoclonal gammopathy: a case series
    Zand, L; Kattah, A; Fervenza, FC
  • Dense deposit disease associated with monoclonal gammopathy of undetermined significance
    Sethi, S; Sukov, WR; Zhang, Y
  • Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients
    Nasr, SH; Valeri, AM; Appel, GB; Sherwinter, J; Stokes, MB; Said, SM; Markowitz, GS; D’Agati, VD
  • C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome
    Lloyd, IE; Gallan, A; Huston, HK; Raphael, KL; Miller, DV; Revelo, MP; Khalighi, MA
  • C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy
    Bomback, AS; Santoriello, D; Avasare, RS; Regunathan-Shenk, R; Canetta, PA; Ahn, W; Radhakrishnan, J; Marasa, M; Rosenstiel, PE; Herlitz, LC; Markowitz, GS; D’Agati, VD; Appel, GB